Komori
Medinet (2370) · InitiativeFirst statedLatest Revision of earnings forecasts (2026-10-16): "Advanced"

Development Plan for a Regenerative Medicine Product for Critical Limb Ischemia

First written in FY2025. 4 of 5 entries say "Advanced", first in 2026-05-13. Latest entry: 2026-10-16.

5entries
2years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2025Advanced2026-05-13 – 2026-10-162025: 120252026: 42026
Same theme, other companies
Development of a regenerative medical product for advanced chronic limb ischemiaA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Moved together

"Commercialization of the Contract Cell-Processing Business" moved the same way as this thread, in the same document, in 2 of its 5 moves.

2222★1234
  1. ★This thread
  2. 1Commercialization of the Contract Cell-Processing Business2×
  3. 2Considering the Acquisition of Domestic and Overseas Cell Therapy Product Pipelines2×
  4. 3Financing Through Third-Party Allotments, Convertible Bonds and Stock Acquisition Rights2×
  5. 4Deficit Offset Through Capital Reduction Without Compensation and Transfer of Surplus2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Medinet yet. It last moved in the Revision of earnings forecasts of 2026-10-16: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.